Ultragenyx Pharmaceutical Inc.【RARE】 業績推移・財務諸表

機能の使い方
(単位:千ドル) 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 4Q21 1Q22 2Q22 3Q22 4Q22 1Q23 2Q23 3Q23 4Q23 1Q24 2Q24 3Q24 4Q24 1Q25 2Q25 3Q25 4Q25
売上高 93 149 - - - - - - - 17 111 5 - - 198 2,414 10,677 12,794 11,763 16,261 18,172 24,149 25,800 35,593 36,309 61,709 81,470 91,542 99,395 86,975 81,647 83,389 79,935 89,343 90,703 103,348 100,496 108,309 98,052 127,392 108,833 147,026 139,494 164,877 139,292 166,496 159,933 207,279
売上成長率(%) - - - - - - - - - - - - - - - - 29.4 28.0 13.2 14.7 25.7
売上原価 - - - - - - - - - - - - - - - - 225 141 273 507 452 766 - - - - - - - - - - - - - - - - - - - - - - - - - -
研究開発費 8,353 11,239 12,854 13,521 17,364 23,104 29,704 44,565 40,415 43,332 48,711 50,746 51,269 58,436 60,412 61,527 75,504 76,835 70,041 71,618 78,105 96,045 100,144 83,061 112,961 80,709 87,314 131,100 147,518 113,205 113,417 123,013 143,155 154,529 237,297 170,808 165,698 164,949 157,245 160,557 178,487 161,503 170,109 187,766 165,772 164,736 216,212 203,280
販売管理費 - - - - - - - - - - - - - - - - 31,435 30,718 31,095 34,476 38,829 39,812 41,006 41,877 47,516 42,252 42,123 51,042 53,258 53,410 53,883 59,431 67,312 68,137 69,841 72,849 76,646 81,403 74,917 76,833 78,160 80,604 80,351 82,495 87,797 86,646 86,620 87,937
営業利益率 (%) - - - - - - - - - -74.2 -102.6 -64.8 -106.9 -54.7
営業利益 -10,339 -13,661 -15,835 -16,943 -21,502 -30,142 -39,936 -56,158 -53,622 -58,053 -65,783 -70,549 -69,954 -78,441 -83,713 -96,834 -96,487 -94,900 -89,646 -90,340 -99,214 -112,474 -118,033 -94,452 -120,665 -63,055 -50,315 -96,081 -106,569 -82,776 -89,828 -102,564 -136,632 -141,593 -225,066 -145,628 -154,105 -147,957 -145,097 -122,049 -165,347 -116,361 -131,987 -122,278 -142,939 -107,888 -170,890 -113,283
営業費用 10,339 13,661 15,835 16,943 21,502 30,142 39,936 56,158 53,622 58,070 65,894 70,554 69,954 78,441 83,911 99,248 107,164 107,694 101,409 106,601 117,386 136,623 143,833 130,045 156,974 124,764 131,785 187,623 205,964 169,751 - - - - - - - - - - - - - - - - - -
経常(税引前)利益 - - - - - - - - - - - - - -72,877 -79,223 -97,948 30,292 -52,626 -87,063 -87,700 -96,540 -98,959 -112,701 -91,244 -118,616 25,730 -68,532 -23,941 -135,762 -121,965 -72,816 -122,438 -151,762 -157,860 -238,819 -153,284 -163,477 -159,096 -158,999 -126,892 -170,229 -130,740 -133,213 -133,404 -149,770 -114,004 -179,540 -127,686
経常(税引前)利益率(%) - - - - - - - - - - - - - - -40011.6 -4057.5 283.7 -411.3 -740.1 -539.3 -531.3 -409.8 -436.8 -256.4 -326.7 41.7 -84.1 -26.2 -136.6 -140.2 -89.2 -146.8 -189.9 -176.7 -263.3 -148.3 -162.7 -146.9 -162.2 -99.6 -156.4 -88.9 -95.5 -80.9 -107.5 -68.5 -112.3 -61.6
法人税等合計 - - - - - - - - - - - - - 14 4 -16,217 39 102 247 126 216 213 293 2,561 409 415 313 70 379 463 182 20 558 302 6,287 -1,451 495 732 650 -3,702 455 858 303 -19 1,310 947 873 870
実効税率(%) - - - - - - - - - - - - - 0.0 -0.9 -0.8 -0.5 -0.7
純利益 -13,630 -13,585 -15,849 -16,738 -21,379 -29,787 -39,232 -55,220 -52,757 -56,923 -64,907 -71,287 -68,290 -72,891 -79,227 -81,731 30,253 -52,728 -87,310 -87,826 -96,756 -99,172 -112,994 -93,805 -119,025 25,315 -68,845 -24,011 -136,141 -122,428 -72,998 -122,458 -152,320 -158,162 -245,106 -151,833 -163,972 -159,828 -159,649 -123,190 -170,684 -131,598 -133,516 -133,385 -151,080 -114,951 -180,413 -128,556
純利益率(%) - - - - - - - - - -80.9 -108.5 -69.0 -112.8 -62.0
一株あたり利益 - - - - - - - - - - - - - - - - 0.63 - - - -1.82 - - - - 0.42 - - - -1.81 - - - - -3.5 -2.16 -2.33 -2.25 -2.23 -1.44 -2.03 -1.52 -1.4 -1.38 -1.57 -1.17 -1.81 -1.28
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - 0.62 - - - -1.82 - - - - 0.41 - - - -1.81 - - - - -3.5 -2.16 -2.33 -2.25 -2.23 -1.44 -2.03 -1.52 -1.4 -1.38 -1.57 -1.17 -1.81 -1.28
EBITDA -113,199 -133,949 -99,269 -162,284 -104,498
EBITDAマージン(%) - - - - - - - - - -68.7 -96.2 -59.6 -101.5 -50.4